Outcomes of primary refractory multiple myeloma and the impact of novel therapies.
Am J Hematol
; 90(11): 981-5, 2015 Nov.
Article
in En
| MEDLINE
| ID: mdl-26214732
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antineoplastic Combined Chemotherapy Protocols
/
Proteasome Inhibitors
/
Immunologic Factors
/
Multiple Myeloma
Type of study:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Am J Hematol
Year:
2015
Document type:
Article